Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

LANTHEUS HOLDINGS, INC.

(LNTH)
  Report
Delayed Nasdaq  -  04:00 2022-09-27 pm EDT
67.39 USD   +1.19%
09/13Lantheus, GE Healthcare Say Study Shows 18F flurpiridaz PET Radiotracer Can Improve Coronary Artery Disease Detection
MT
09/13GE Healthcare and Lantheus Phase III Clinical Trial Finds [18F]flurpiridaz PET Radiotracer Could Improve Detection of Coronary Artery Disease
GL
09/13GE Healthcare and Lantheus Phase III Clinical Trial Finds flurpiridaz PET Radiotracer Could Improve Detection of Coronary Artery Disease
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
All news about LANTHEUS HOLDINGS, INC.
09/13Lantheus, GE Healthcare Say Study Shows 18F flurpiridaz PET Radiotracer Can Improve Cor..
MT
09/13GE Healthcare and Lantheus Phase III Clinical Trial Finds [18F]flurpiridaz PET Radiotra..
GL
09/13GE Healthcare and Lantheus Phase III Clinical Trial Finds flurpiridaz PET Radiotracer C..
AQ
09/13GE Healthcare and Lantheus Holdings Inc Announces Phase III Clinical Trial Finds [╣8F]f..
CI
09/13GE, Lantheus Say Heart Disease Tracer Trial Met Key Endpoints
DJ
09/08Insider Sell: Lantheus Holdings
MT
09/08Insider Sell: Lantheus Holdings
MT
09/01Lantheus to Present at the Wells Fargo Healthcare Conference
GL
08/25Lantheus Holdings Shares Rise After B. Riley Resumes Coverage
MT
08/25B. Riley Securities Resumes Lantheus Holdings at Buy with $102 PT, Views as 'Best Posit..
MT
08/22Insider Sell: Lantheus Holdings
MT
08/15Insider Sell: Lantheus Holdings
MT
08/11Insider Sell: Lantheus Holdings
MT
08/05SVB Securities Raises Lantheus Holdings Price Target to $110 From $100, Maintains Outpe..
MT
08/04Lantheus Reports Increase in Q2 Adjusted Net Income, Revenue; Raises 2022 Targets
MT
08/04Lantheus Holdings to Seek Acquisitions
CI
08/04Transcript : Lantheus Holdings, Inc., Q2 2022 Earnings Call, Aug 04, 2022
CI
08/04LANTHEUS HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition an..
AQ
08/04Lantheus : Reports Second Quarter 2022 Financial Results - Form 8-K
PU
08/04Lantheus Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months ..
CI
08/04Lantheus Holdings : Q2 Earnings Snapshot
AQ
08/04Lantheus : Q2 2022 Reconciliation of GAAP to Non-GAAP Financial Measures
PU
08/04GUIDANCE: (LNTH) LANTHEUS HOLDINGS Sees Q3 EPS Range $0.80 - $0.85
MT
08/04Lantheus Reports Second Quarter 2022 Financial Results
GL
08/04Lantheus Reports Second Quarter 2022 Financial Results
AQ
08/04GUIDANCE: (LNTH) LANTHEUS HOLDINGS Sees Fiscal Year 2022 EPS Range $3.50 - $3.6..
MT
08/04Earnings Flash (LNTH) LANTHEUS HOLDINGS Reports Q2 Revenue $223.7M
MT
08/04Earnings Flash (LNTH) LANTHEUS HOLDINGS Posts Q2 EPS $0.89
MT
08/04Lantheus Holdings, Inc. Updates Earnings Guidance for the Full Year 2022
CI
08/04Lantheus Holdings, Inc. Provides Earnings Guidance for the Third Quarter 2022
CI
08/04Radiopharm Theranostics Enters Strategic Collaboration, Acquires Rights for Nanobody Im..
MT
08/03Radiopharm Theranostics Enters Collaboration Agreement with Lantheus for the Mutually B..
CI
07/21Lantheus Holdings To Host Second Qua : 00 a.m. Eastern Time
GL
07/19Insider Sell: Lantheus Holdings
MT
06/24Lantheus Holdings, Inc.(NasdaqGM:LNTH) dropped from Rus..
CI
06/24Lantheus Holdings, Inc.(NasdaqGM:LNTH) dropped from Rus..
CI
06/24Lantheus Holdings, Inc.(NasdaqGM:LNTH) dropped from Rus..
CI
06/24Lantheus Holdings, Inc.(NasdaqGM:LNTH) dropped from Rus..
CI
06/24Lantheus Holdings, Inc.(NasdaqGM:LNTH) dropped from Rus..
CI
06/24Lantheus Holdings, Inc.(NasdaqGM:LNTH) dropped from Rus..
CI
06/24Lantheus Holdings, Inc.(NasdaqGM:LNTH) dropped from Rus..
CI
06/24Lantheus Holdings, Inc.(NasdaqGM:LNTH) dropped from Rus..
CI
06/24Lantheus Holdings, Inc.(NasdaqGM:LNTH) dropped from Rus..
CI
06/24Lantheus Holdings, Inc.(NasdaqGM:LNTH) dropped from Rus..
CI
06/24Lantheus Holdings, Inc.(NasdaqGM:LNTH) dropped from Rus..
CI
06/24Lantheus Holdings, Inc.(NasdaqGM:LNTH) dropped from Rus..
CI
06/24Lantheus Holdings, Inc.(NasdaqGM:LNTH) dropped from Rus..
CI
06/15Lantheus Names Paul Blanchfield as Chief Operating Officer
MT
06/15Lantheus : Announces Promotion of Paul Blanchfield to Chief Operating Officer - Form 8-K
PU
06/15Lantheus Holdings, Inc. : Change in Directors or Principal Officers, Financial Statements ..
AQ
06/15Lantheus Announces Promotion of Paul Blanchfield to Chief Operating Officer
GL
06/15Lantheus Announces Promotion of Paul Blanchfield to Chief Operating Officer
AQ
06/15Lantheus Holdings, Inc. Announces Executive Changes
CI
06/13Lantheus Holdings, Inc Highlights Preliminary Study Results Demonstrating Potential of ..
CI
06/13Lantheus Highlights Preliminary Study Results Demonstrating Potential of NM-01, a Novel..
GL
06/13Lantheus Highlights Preliminary Study Results Demonstrating Potential of NM-01, a Novel..
GL
06/13Lantheus' PYLARIFY AI™ Platform Demonstrates Higher Efficiency and Consistency Wh..
GL
06/13Lantheus' PYLARIFY AI™ Platform Demonstrates Higher Efficiency and Consistency Wh..
AQ
06/13Lantheus’ PYLARIFY AI™ Platform Demonstrates Higher Efficiency and Consistenc..
CI
06/10Ratio Therapeutics, Inc. announced that it has received $20 million in funding from Bay..
CI
06/06SVB Securities Assumes Lantheus Holdings at Outperform with $100 Price Target
MT
06/02Lantheus to Present at the Jefferies Healthcare Conference
GL
05/26Lantheus Announces Presentations Featuring PYLARIFY« (Piflufolastat F18), PYLARIFY AI&t..
GL
05/24Transcript : Lantheus Holdings, Inc. Presents at UBS Global Healthcare Confer..
CI
05/17Insider Sell: Lantheus Holdings
MT
05/17Transcript : Lantheus Holdings, Inc. - Analyst/Investor Day
CI
05/17Lantheus Holdings, Inc. : Regulation FD Disclosure, Financial Statements and Exhibits (for..
AQ
05/16Lantheus Hosts Inaugural Investor Day
GL
05/16Lantheus Hosts Inaugural Investor Day
AQ
05/16Lantheus Holdings, Inc. Presents Results from a PYLARIFY AI™ Study at the American..
CI
05/16Lantheus Presents Results from a PYLARIFY AI™ Study at the American Urological As..
GL
05/13Sector Update: Health Care Stocks Gain Premarket Friday
MT
05/13Lantheus Holdings Starts Dosing Patients in Phase 2 Trial to Asses PD-L1 Expression in ..
MT
05/13Lantheus Announces First Patient Dosed in Phase 2 Clinical Trial of NM-01 to Monitor PD..
GL
05/13Lantheus Announces First Patient Dosed in Phase 2 Clinical Trial of NM-01 to Monitor PD..
AQ
1  2  3  4  5  6  7  8  9Next
Upcoming event on LANTHEUS HOLDINGS, INC.